세계의 힘줄 동종이식 시장 규모 조사 : 제품 유형별, 최종사용자별, 지역별 예측(2022-2032년)

The Global Tendon Allograft Market is valued approximately at USD 67.39 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 5.2% over the forecast period 2024-2032. Tendon allografts, harvested from human cadavers, are increasingly preferred for orthopedic surgeries to repair torn or damaged tendons due to their efficiency in reducing surgery time and avoiding additional injuries to the patient's tissues. The advancements in tendon allograft processing and preservation techniques have significantly extended the shelf life of allografts, ensuring a ready supply for surgical procedures without compromising on quality. This technological progression in tissue preservation methods is pivotal in driving market growth.

Moreover, innovations in sterilization and processing methods, such as decellularization, have enhanced the safety and efficacy of tendon allografts by eliminating pathogens and minimizing immunogenicity. These improvements reduce the risk of graft rejection and ensure the retention of biomechanical properties, thereby increasing the preference for allografts among surgeons and patients. However, the market faces challenges such as the high cost of allograft procedures, stringent regulatory requirements, and limited availability of donor tissues, which can hinder market growth. Despite these challenges, the market is poised for growth due to the rising adoption of minimally invasive surgical techniques and the increasing incidence of sports-related injuries. These techniques, which involve smaller incisions and specialized instruments, offer benefits such as shorter recovery times and reduced postoperative pain, further boosting the demand for tendon allografts. Additionally, expanding applications in new materials and composites required for next-generation products in clean energy and space exploration are expected to bolster market growth.

The key regions considered for the Global Tendon Allograft Market study include Asia Pacific, North America, Europe, Latin America, and Middle East and Africa. In year 2023, North America led the global tendon allograft market. This dominance is attributed to the high incidence of sports-related injuries, such as ACL tears, rotator cuff tears, and Achilles tendon ruptures. With the increasing participation in sports and physical activities, the demand for tendon allografts for reconstructive surgeries among athletes and active individuals is rising. Additionally, North America is a hub for medical innovation, with continuous advancements in tissue processing techniques, surgical instrumentation, and rehabilitation protocols. Cutting-edge technologies, including minimally invasive surgical techniques, tissue engineering, and biologic augmentation, are driving the growth of the tendon allograft market by enhancing surgical outcomes and patient recovery. Moreover, Asia Pacific is projected to registered fastest growth in the forecasted period 2024-2032.

Major market players included in this report are:

• Aesculap
• Lattice Biologics Ltd.
• MTF Biologics
• LifeNet Health
• Integra LifeSciences Corporation
• RTI Surgical
• Tissue Banks International
• AlloSource
• Arthrex
• Zimmer Biomet Holdings Inc.
• Medtronic PLC
• Stryker Corporation
• Johnson & Johnson
• Smith & Nephew
• ConMed Corporation

The detailed segments and sub-segment of the market are explained below:

Product Type:

• Achilles Tendon
• Tibialis
• Patellar Tendon
• Others

By End User:

• Hospitals
• Orthopedic Clinics
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Tendon Allograft Market Executive Summary

• 1.1. Global Tendon Allograft Market Size & Forecast (2022- 2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Product Type
  • 1.3.2. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Tendon Allograft Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global Tendon Allograft Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Technological advancements in tendon allograft processing and preservation
  • 3.1.2. Increasing adoption of minimally invasive surgical techniques
  • 3.1.3. Rising incidence of sports-related injuries
• 3.2. Market Challenges
  • 3.2.1. High cost of allograft procedures and equipment
  • 3.2.2. Stringent regulatory requirements
  • 3.2.3. Limited availability of donor tissues
• 3.3. Market Opportunities
  • 3.3.1. Innovations in tissue processing and sterilization techniques
  • 3.3.2. Expanding applications in new materials and composites

Chapter 4. Global Tendon Allograft Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Tendon Allograft Market Size & Forecasts by Product Type 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global Tendon Allograft Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 5.2.1. Achilles Tendon
  • 5.2.2. Tibialis
  • 5.2.3. Patellar Tendon
  • 5.2.4. Others

Chapter 6. Global Tendon Allograft Market Size & Forecasts by End User 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global Tendon Allograft Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Billion)
  • 6.2.1. Hospitals
  • 6.2.2. Orthopedic Clinics
  • 6.2.3. Others

Chapter 7. Global Tendon Allograft Market Size & Forecasts by Region 2022-2032

• 7.1. North America Tendon Allograft Market
  • 7.1.1. U.S. Tendon Allograft Market
    • 7.1.1.1. Product Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. End User breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Tendon Allograft Market
• 7.2. Europe Tendon Allograft Market
  • 7.2.1. U.K. Tendon Allograft Market
  • 7.2.2. Germany Tendon Allograft Market
  • 7.2.3. France Tendon Allograft Market
  • 7.2.4. Spain Tendon Allograft Market
  • 7.2.5. Italy Tendon Allograft Market
  • 7.2.6. Rest of Europe Tendon Allograft Market
• 7.3. Asia-Pacific Tendon Allograft Market
  • 7.3.1. China Tendon Allograft Market
  • 7.3.2. India Tendon Allograft Market
  • 7.3.3. Japan Tendon Allograft Market
  • 7.3.4. Australia Tendon Allograft Market
  • 7.3.5. South Korea Tendon Allograft Market
  • 7.3.6. Rest of Asia Pacific Tendon Allograft Market
• 7.4. Latin America Tendon Allograft Market
  • 7.4.1. Brazil Tendon Allograft Market
  • 7.4.2. Mexico Tendon Allograft Market
  • 7.4.3. Rest of Latin America Tendon Allograft Market
• 7.5. Middle East & Africa Tendon Allograft Market
  • 7.5.1. Saudi Arabia Tendon Allograft Market
  • 7.5.2. South Africa Tendon Allograft Market
  • 7.5.3. Rest of Middle East & Africa Tendon Allograft Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Aesculap
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. Lattice Biologics Ltd.
  • 8.3.3. MTF Biologics
  • 8.3.4. LifeNet Health
  • 8.3.5. Integra LifeSciences Corporation
  • 8.3.6. RTI Surgical
  • 8.3.7. Tissue Banks International
  • 8.3.8. AlloSource
  • 8.3.9. Arthrex
  • 8.3.10. Zimmer Biomet Holdings Inc.
  • 8.3.11 Medtronic PLC
  • 8.3.12 Stryker Corporation
  • 8.3.13 Johnson & Johnson
  • 8.3.14 Smith & Nephew
  • 8.3.15 ConMed Corporation

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes